ASP Isotopes Files 8-K Report
Ticker: ASPI · Form: 8-K · Filed: Sep 29, 2025 · CIK: 1921865
Sentiment: neutral
Topics: regulatory-filing, 8-k
TL;DR
ASP Isotopes filed an 8-K, but no juicy details yet.
AI Summary
ASP Isotopes Inc. filed an 8-K report on September 29, 2025, to disclose other events and financial statements. The filing does not contain specific financial figures or details about the nature of the 'other events' beyond its classification as a current report.
Why It Matters
This 8-K filing indicates that ASP Isotopes Inc. has made a regulatory submission, but it lacks specific details about the events or financial information being reported.
Risk Assessment
Risk Level: low — The filing is a standard 8-K current report with no disclosed material events, financial changes, or forward-looking statements.
Key Players & Entities
- ASP Isotopes Inc. (company) — Registrant
- September 29, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-41555 (identifier) — Commission File Number
- 87-2618235 (identifier) — IRS Employer Identification No.
- 601 Pennsylvania Avenue NW, South Building, Suite 900 Washington, DC 20004 (address) — Principal executive offices
- (202) 756-2245 (phone_number) — Registrant's telephone number
FAQ
What specific 'Other Events' are being reported by ASP Isotopes Inc. in this 8-K filing?
The filing does not specify the nature of the 'Other Events' beyond its classification as a current report item.
Does this 8-K filing contain any new financial statements or updates for ASP Isotopes Inc. as of September 29, 2025?
The filing indicates 'Financial Statements and Exhibits' as an item, but the document itself does not contain specific financial figures or details within the provided text.
What is the principal business of ASP Isotopes Inc. based on its SIC code?
ASP Isotopes Inc. is classified under SIC code 2890, which corresponds to Miscellaneous Chemical Products.
Where are ASP Isotopes Inc.'s principal executive offices located?
The principal executive offices of ASP Isotopes Inc. are located at 601 Pennsylvania Avenue NW, South Building, Suite 900, Washington, DC 20004.
When was this 8-K report filed by ASP Isotopes Inc.?
This 8-K report was filed on September 29, 2025.
Filing Stats: 493 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2025-09-29 11:08:52
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 ASPI The Nasdaq Stock Market LLC
Filing Documents
- aspi_8k.htm (8-K) — 26KB
- aspi_ex991.htm (EX-99.1) — 23KB
- aspi_ex991img1.jpg (GRAPHIC) — 3KB
- 0001477932-25-007115.txt ( ) — 179KB
- aspi-20250929.xsd (EX-101.SCH) — 5KB
- aspi-20250929_lab.xml (EX-101.LAB) — 15KB
- aspi-20250929_cal.xml (EX-101.CAL) — 1KB
- aspi-20250929_pre.xml (EX-101.PRE) — 10KB
- aspi-20250929_def.xml (EX-101.DEF) — 2KB
- aspi_8k_htm.xml (XML) — 4KB
01. Other Events
Item 8.01. Other Events. On September 29 2025, ASP Isotopes Inc. (the "Company") issued a press release announcing changes to the executive management teams of ASP Isotopes Inc. and its subsidiary, Quantum Leap Energy LLC, effective October 1, 2025. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference, other than the third, fourth, fifth, sixth and seventh paragraphs of the press release.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release, dated September 29, 2025, of ASP Isotopes Inc. announcing changes to the executive management teams of ASP Isotopes Inc. and its subsidiary, Quantum Leap Energy LLC, effective October 1, 2025. 104 Cover Page Interactive Date File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASP ISOTOPES INC. Date: September 29, 2025 By: /s/ Donald G. Ainscow Name: Donald G. Ainscow Title: Executive Vice President, General Counsel and Secretary 3